Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Sahana Ramanathan, Govindaraju Archunan, Muthusamy Sivakumar, Subramanian Tamil Selvan, A Lenin Fred, Sundramurthy Kumar, Balázs Gulyás & Parasuraman Padmanabhan. (2018) Theranostic applications of nanoparticles in neurodegenerative disorders. International Journal of Nanomedicine 13, pages 5561-5576.
Read now
Read now
Peter Hinow, Ami Radunskaya, Sean M. Mackay, John N. J. Reynolds, Morgan Schroeder, Eng Wui Tan & Ian G. Tucker. (2016) Signaled drug delivery and transport across the blood–brain barrier. Journal of Liposome Research 26:3, pages 233-245.
Read now
Read now
Olivier Rascol & Santiago Perez-Lloret. (2009) Rotigotine transdermal delivery for the treatment of Parkinson's disease. Expert Opinion on Pharmacotherapy 10:4, pages 677-691.
Read now
Read now
Dag Nyholm & Hans Lennernäs. (2008) Irregular gastrointestinal drug absorption in Parkinson's disease. Expert Opinion on Drug Metabolism & Toxicology 4:2, pages 193-203.
Read now
Read now
Articles from other publishers (22)
Bhumika Kumar, Mukesh Pandey, Faheem H. Pottoo, Faizana Fayaz, Anjali Sharma & P.K. Sahoo. (2020) Liposomes: Novel Drug Delivery Approach for Targeting Parkinson’s Disease. Current Pharmaceutical Design 26:37, pages 4721-4737.
Crossref
Crossref
Magisetty Obulesu. 2020. Parkinson's Disease Therapeutics. Parkinson's Disease Therapeutics
25
38
.
Magisetty Obulesu. 2020. Parkinson's Disease Therapeutics. Parkinson's Disease Therapeutics
1
11
.
Miguel Rosa-Grilo, Mubasher A. Qamar, Raquel N. Taddei, Javier Pagonabarraga, Jaime Kulisevsky, Anna Sauerbier & K. Ray Chaudhuri. (2017) Rotigotine transdermal patch and sleep in Parkinson’s disease: where are we now?. npj Parkinson's Disease 3:1.
Crossref
Crossref
. 2016. Controlled Release Systems. Controlled Release Systems
441
464
.
Jorge FONSECA & Carla Adriana SANTOS. (2015) PERCUTANEOUS ENDOSCOPIC GASTROSTOMY WITH JEJUNAL EXTENSION PLUS PERCUTANEOUS ENDOSCOPIC GASTROSTOMY (PEG-J PLUS PEG) IN PATIENTS WITH GASTRIC/DUODENAL CANCER OUTLET OBSTRUCTION. Arquivos de Gastroenterologia 52:1, pages 72-75.
Crossref
Crossref
Karen Chan, Ravijyot Saggu, Helen Milbourn & Matthew Hayman. (2013) Management of medication in patients with Parkinson's disease who are nil-by-mouth. British Journal of Hospital Medicine 74:Sup8, pages C120-C123.
Crossref
Crossref
Alim Louis Benabid, John Mitrofanis, Stéphan Chabardés, Eric Seigneuret, Napoleon Torres, Brigitte Piallat, Abdelhamid Benazzouz, Valerie Fraix, Paul Krack, Pierre Pollak, Sylvie Grand & Jean François LeBas. 2011. Youmans Neurological Surgery. Youmans Neurological Surgery
944
962
.
Santiago Perez-Lloret & Olivier Rascol. (2010) Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinsonʼs Disease. CNS Drugs 24:11, pages 941-968.
Crossref
Crossref
Peter Jenner. (2009) From the MPTP-treated primate to the treatment of motor complications in Parkinson's disease. Parkinsonism & Related Disorders 15, pages S18-S23.
Crossref
Crossref
O.K. Sujith & Carol Lane. (2009) Review: Therapeutic options for continuous dopaminergic stimulation in Parkinson's disease. Therapeutic Advances in Neurological Disorders 2:2, pages 105-113.
Crossref
Crossref
Alim Louis Benabid, Stephan Chabardes, John Mitrofanis & Pierre Pollak. (2009) Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. The Lancet Neurology 8:1, pages 67-81.
Crossref
Crossref
A. L. Benabid, J. Mitrofanis, S. Chabardes, E. Seigneuret, N. Torres, B. Piallat, A. Benazzouz, V. Fraix, P. Krack, P. Pollak, S. Grand & J. F. LeBas. 2009. Textbook of Stereotactic and Functional Neurosurgery. Textbook of Stereotactic and Functional Neurosurgery
1603
1630
.
G. Linazasoro. (2008) Potential applications of nanotechnologies to Parkinson's disease therapy. Parkinsonism & Related Disorders 14:5, pages 383-392.
Crossref
Crossref
M.A. De Souza Silva, B. Topic, J.P. Huston & C. Mattern. (2007) Intranasal dopamine application increases dopaminergic activity in the neostriatum and nucleus accumbens and enhances motor activity in the open field. Synapse 62:3, pages 176-184.
Crossref
Crossref
Gaia A. Scalabrino, Nicola Hogan, Kathy M. O'Boyle, Gillian R. Slator, Daniel J. Gregg, Christopher M. Fitchett, Sylvia M. Draper, Geoffrey W. Bennett, Patricia M. Hinkle, Karl Bauer, Carvell H. Williams, Keith F. Tipton & Julie A. Kelly. (2007) Discovery of a dual action first-in-class peptide that mimics and enhances CNS-mediated actions of thyrotropin-releasing hormone. Neuropharmacology 52:7, pages 1472-1481.
Crossref
Crossref
Henry R. Costantino, Lisbeth Illum, Gordon Brandt, Paul H. Johnson & Steven C. Quay. (2007) Intranasal delivery: Physicochemical and therapeutic aspects. International Journal of Pharmaceutics 337:1-2, pages 1-24.
Crossref
Crossref
G O’KeeffeRA Barker. (2007) Cell repair in Parkinson’s disease. Future Neurology 2:2, pages 209-217.
Crossref
Crossref
Neha Singh, Viness Pillay & Yahya E. Choonara. (2007) Advances in the treatment of Parkinson's disease. Progress in Neurobiology 81:1, pages 29-44.
Crossref
Crossref
Shridhar Hegde & Michelle Schmidt. 2007. Annual Reports in Medicinal Chemistry Volume 42. Annual Reports in Medicinal Chemistry Volume 42
505
554
.
Stanley Fahn, Joseph Jankovic, Mark Hallett & Peter Jenner. 2007. Principles and Practice of Movement Disorders. Principles and Practice of Movement Disorders
205
231
.
Elizabeth J. MeredithMichelle J. HolderAnders RosénAdrian Drake LeeMartin J. S. Dyer, Nicholas M. Barnes & John Gordon. (2006) Dopamine targets cycling B cells independent of receptors/transporter for oxidative attack: Implications for non-Hodgkin’s lymphoma. Proceedings of the National Academy of Sciences 103:36, pages 13485-13490.
Crossref
Crossref